Regulation of tumor dormancy and role of microenvironment: a mathematical model

Adv Exp Med Biol. 2013:734:237-59. doi: 10.1007/978-1-4614-1445-2_11.

Abstract

Herein, a mathematical model of a molecular control system for the regulation of secondary tumors is formulated and analyzed to explore how secondary tumors can be controlled by a primary tumor with/without a surgery and the microenvironment. This control system is composed of fibroblast growth factor-2 (FGF2), urokinase-type plasminogen activator (uPA), plasmin, transforming growth factor-beta (TGFβ), latent TGFβ (LTGFβ), and tumor density. The control of secondary tumors by primary tumors was first modeled by Boushaba, Nilsen-Hamiton and Levine in [46]. The model is based on the idea that the vascularization of a secondary tumor can be suppressed by inhibitors from a larger primary tumor. The emergence of tumors at secondary sites 5-7 cm from a primary site was observed after surgical removal of the primary tumor in silico. The model supports the notion that the fate of secondary tumors after surgery depends on the distance from the primary tumor and the surrounding microenvironment. As such, the primary tumor did not influence the growth of remote secondary tumors, but it could effectively suppress the growth of the secondary tumors if they were too close to the primary tumor, even after it was removed. Thus, the model predicts the emergence of secondary tumors after the excision of the primary tumor when the distance between these tumors is in the "distance window." It also predicts that the growth behaviors of the secondary tumors depend on the local microenvironment. Based on these findings, we propose several treatment options for better clinical outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacology
  • Cell Count
  • Cell Death
  • Computer Simulation
  • Diffusion
  • Extracellular Matrix / pathology
  • Fibrinolysin / metabolism
  • Fibroblast Growth Factor 2 / administration & dosage
  • Fibroblast Growth Factor 2 / pharmacology
  • Half-Life
  • Humans
  • Models, Biological*
  • Neoplasm Metastasis / drug therapy*
  • Neoplasm Metastasis / pathology
  • Neoplasms / drug therapy
  • Neoplasms / pathology*
  • Neoplasms / surgery
  • Plasminogen / analysis
  • Time Factors
  • Transforming Growth Factor beta / administration & dosage
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta / pharmacology
  • Tumor Microenvironment*
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / pharmacology

Substances

  • Antineoplastic Agents
  • Transforming Growth Factor beta
  • Fibroblast Growth Factor 2
  • Plasminogen
  • Fibrinolysin
  • Urokinase-Type Plasminogen Activator